 Ondansetron
"Ondansetron" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Descriptor ID |
D017294
|
| MeSH Number(s) |
D03.383.129.308.690 D03.438.473.144.500 D03.494.148.500
|
| Concept/Terms |
Ondansetron Hydrochloride- Ondansetron Hydrochloride
- Hydrochloride, Ondansetron
- Ondansetron Monohydrochloride Dihydrate
- Dihydrate, Ondansetron Monohydrochloride
- Monohydrochloride Dihydrate, Ondansetron
- Ondansetron Monohydrochloride
- Monohydrochloride, Ondansetron
|
Below are MeSH descriptors whose meaning is more general than "Ondansetron".
Below are MeSH descriptors whose meaning is more specific than "Ondansetron".
This graph shows the total number of publications written about "Ondansetron" by people in this website by year, and whether "Ondansetron" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 0 | 1 | | 2021 | 0 | 1 | 1 | | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ondansetron" by people in Profiles.
-
Black K, Brenn BR, Gaedigk A, Wanderer JP, Van Driest SL. Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron. Clin Transl Sci. 2023 02; 16(2):269-278.
-
Edwards A, Teusink-Cross A, Martin LJ, Prows CA, Mehta PA, Ramsey LB. Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series. Clin Transl Sci. 2022 03; 15(3):610-618.
-
Bell GC, Caudle KE, Whirl-Carrillo M, Gordon RJ, Hikino K, Prows CA, Gaedigk A, Agundez J, Sadhasivam S, Klein TE, Schwab M. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron. Clin Pharmacol Ther. 2017 08; 102(2):213-218.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|